Clinical Trials Browser

Phase 1/2 × Rhabdoid Tumor × Ipilimumab × Clear all

NCT05407441 2025-10-03

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Phase 1/2 Recruiting

Chordoma, Sarcoma, Rhabdoid Tumor